Another special issue

Although I already have one special issue under editing, I was invited to have another one, which I couldn't say no to... This one is under the title "Novel Strategies for Cancer Targeted Delivery" in journal called "Pharmaceutics" and I will edit together with my dear colleague, Dr. Magdalena Markowicz-Piasecka. We have already received few submission, so please contribute, the original deadline is on 28th of February, 2022, but I think we will try to postpone a bit. 

 

Dear Colleagues,

Among the controlled drug delivery technologies, targeted drug delivery has attracted the attention of researchers, as it comprises the systemic delivery of a drug carrier system to specific cell types, tissues, or organs. Targeted drug delivery systems would mainly be beneficial in diseases such as cancers, which are a leading cause of death worldwide. Advancements in omic sciences, analytical procedures, and high-throughput screening in the last two decades have led to the realization that cancer is more complex than was originally conceived. Numerous challenges impede effective cancer treatment and development of effective drugs such as ineffective therapeutic drug concentrations reaching the tumor site, life-threatening side effects caused by nonspecific tissue distribution of anti-neoplastic agents, and acquired resistance of cancer cells upon chemotherapy that triggers cross-resistance to a wide range of different drugs. The complexity of cancers requires the development of very delicate approaches in the course of the drug discovery pipeline.

In line with the challenges raised by the complexity of cancer, the aim of the present thematic issue is to provide state-of-the-art information on novel drug delivery systems in order to enhance the selective uptake of cytotoxic agents by tumor cells and spare normal cells. In this Special Issue, we invite you to contribute both new basic findings about innovative molecularly targeted cancer therapies and entrepreneurial methods of drug delivery in cancer, and your exploratory or confirmatory studies testing novel nanoparticle-based delivery systems or vaccine design against cancer. We are also interested in your critical contributions about potential pitfalls in cancer targeted drug delivery approaches, leading to a comprehensive overview about the current methods for drug delivery.

Dr. Magdalena Markowicz-Piasecka
Dr. Kristiina Huttunen
Guest Editors

Click here to the website!

P.S. If you are looking for a more transporter-related special issues, we still have the special issue, edited together with Santosh, called "Transporter-Mediated Drug Delivery" open for submissions until 1st of March, 2022.

Click here to the website!